new and special drug
Lynparza (Olaparib) – Ovarian Cancer | HongKong DengYue Medicine
Lenvima (Lenvatinib) – HCC | HongKong DengYue Medicine
Prezcobix (Darunavir and Cobicistat) – HIV | HongKong DengYue Medicine
Praxbind (Idarucizumab) – Dabigatran Toxicity | HongKong DengYue Medicine
Albuvirtide Injection (Aikening) – HIV | HongKong DengYue Medicine
Deltyba (delamanid) – MDR-TB | HongKong DengYue Medicine
Eylea (aflibercept) – Diabetic Retinopathy | HongKong DengYue Medicine
Daboshu (Sintilimab Injection) – Lung Cancer | HongKong DengYue Medicine
Tofidence (Tocilizumab) – Immunology | HongKong DengYue Medicine
Quinlock Ripretinib – GIST | HongKong DengYue Medicine
Orkedia (Evocalcet) | Secondary Hyperparathyroidism | DengYue
Tremfya (Guselkumab) | Plaque Psoriasis | DengYue Medicine
Entyvio (Vedolizumab) | Ulcerative Colitis | DengYue Medicine
Hengmu (Tenofovir Amibufenamide) | CHB | HongKong DengYue
Litfulo (Ritlecitinib) | Severe Alopecia Areata | DengYue Medicine
Leqvio (Inclisiran) | ASCVD | HongKong DengYue Medicine
